Whitehawk Therapeutics, Inc.
WHWKBiotechnology
$3.30−4.62%As of Oct 29vs prior close
- Market cap
- $188.1M
- P/E (TTM)
- –
- From 52W high
- −35.29%
- EPS (YE25)
- -$0.33
- Revenue (YE25)
- $7.1M
- Net margin
- -288.26%
Nomior Score
51
Steady ProfileTop 49% of the scored universe
Growth44
Quality44
Value45
Momentum79
Resilience44
Growth
−13.77%revenue a year over 7 fiscal years
YE18 $20.2MYE25 $7.1M
Connections
Revenue to profitQ1 YE25
The operating loss was 213% of revenue, narrower by 152 pts on a year.
Who owns it
2funds